Showing results (1601-1610 of 2,171) with videos related to
Sort By:
Pageof 218
International Journal of Radiation Applications and Instrumentation. Part D, Nuclear Tracks and Radiation Measurements|January 1, 1992
Ionizing radiation exposure of LDEF (pre-recovery estimates)E V Benton, W Heinrich, T A Parnell, et al.The Journal of Organic Chemistry|September 26, 2025
Synthesis and Isomerization of Tetrahydro-4<i>H</i>-chromene DerivativesRyan Jacob Burk, Anasuya Ghorai, James X Mao, et al.American Heart Journal|December 9, 2019
High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarctionJay S Shavadia, Christopher B Granger, Wendimagegn Alemayehu, et al.American Heart Journal|November 2, 2013
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction studyAkshay Bagai, Paul W Armstrong, Amanda Stebbins, et al.Heart (British Cardiac Society)|March 19, 2005
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trialR C Welsh, W Chang, P Goldstein, et al.Circulation|August 10, 2000
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trialB F Uretsky, K Thygesen, P W Armstrong, et al.American Heart Journal|May 22, 2012
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trialRajendra H Mehta, Padma Kaul, Renato D Lopes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) erasNancy F Crum, Robert H Riffenburgh, Scott Wegner, et al.Chemical Communications (Cambridge, England)|November 23, 2016
Ultrafast chiral separations for high throughput enantiopurity analysisChandan L Barhate, Leo A Joyce, Alexey A Makarov, et al.JAMA|January 4, 2007
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial, Paul W Armstrong, Christopher B Granger, et al.Pageof 218